However, TP53 and Rb1 loss is frequent in NEC, almost all the data exclusively are for GI-NEC and few data showed that NECB has a markedly low rate of these mutations (<7%) [15]. This evidence concerns the gene RB1 and neuroendocrine carcinoma.